At the request of the Food and Drug Administration, an IOM committee examined the global effects of falsified, substandard and counterfeit drugs in a report, “Countering the Problem of Falsified and Substandard Drugs.”
Click here to read the full report on IOM’s recommendations in Becker’s ASC Review.
